Metastatic Melanoma Tumors (IMAGE)
Caption
Metastatic melanoma tumors. Left exhibits low or absent expression of RASA2 and reduced survival, typical of about 35 percent of patients. The sample on the right exhibits high RASA2 expression and increased survival.
Credit
Weizmann Institute of Science
Usage Restrictions
None
License
Licensed content